Search This Blog

Monday, April 13, 2026

ImageneBio announces $30 million private placement

 

ImageneBio announces $30 million private placement of pre-funded warrants with institutional investors to fund IMG-007 development

  • Proceeds will support ongoing development of lead drug candidate IMG-007 for atopic dermatitis and alopecia areata.


Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)